DEVELOPING STRATEGY FOR BETTER HEALTH OUTCOMES FROM A PRODUCTIVE AND EFFICIENT RESEARCH ECOSYSTEM National Health and Medical Research Council (NHMRC) CEO Outlines Priorities
With
Professor Steve Wesselingh,
Chief Executive Officer,
National Health and Medical Research Council (NHMRC)
AUSTRALIAN HEALTH JOURNAL SEGMENT
Filmed in Canberra | June 2025
Professor Steve Wesselingh serves as the CEO of NHMRC, having initially trained as an infectious diseases doctor. His career includes prominent roles such as Head of the Infectious Diseases Unit at the Alfred Hospital, Director of the Burnett, Dean of Medicine at Monash University, and the inaugural Director of SAHMRI. Under his leadership, NHMRC plays a critical role in funding health and medical research, allocating approximately a billion dollars annually to investigator-led projects, clinical trials, and various strategic initiatives. NHMRC also collaborates internationally with organisations such as the MRC and the EU, and manages grant allocation for the MRFF, which distributes $650 million each year.
An important aspect of NHMRC’s mission is to ensure the integrity of research conducted in Australia, which is essential for maintaining public trust. The organisation oversees the accreditation of human research ethics committees nationwide and is involved in developing and endorsing clinical guidelines. Professor Wesselingh emphasises the urgency of promoting the benefits of health and medical research in the face of recent skepticism toward science and institutions.
Prof Wesselingh advocates for the integration of research into clinical care, arguing that such an approach enhances patient outcomes and promotes equity in access to innovative treatments across urban and rural areas. Each year, NHMRC hosts an awards event to recognise the achievements of Australia’s top researchers, underscoring the organisation’s commitment to advancing high-quality science and its impact on healthcare.
Currently NHMRC is developing a National Health and Medical Research Strategy that aims provide national direction, build on Australia’s strengths in the health and medical research sector, fill gaps, and continue to attract researchers and investors to Australia. Professor talks about Australia needing a national health and research strategy, echoed by groups such as Association of Australian Medical Research Institutes (AAMRI) in recent years. The formation of the strategy is underway under Ms Rosemary Huxtable AO PSM, as Chair of the National Strategy with the draft scheduled to be released by early July 2025.
Source: Written by AUDIENCED
You Might also like
-
Impact of genetic pathologist role across medicine
Dr Marina Berbic is a genetic pathologist and the Deputy Director of Genetics at Douglass Hanly Moir Pathology – a laboratory based in Sydney and part of Sonic Healthcare. The genetics department at Douglass Hanly Moir offers a wider array of genetic tests across many domains, and the medical leadership model ensures the highest possible standard of care and commitment to patient safety.
-
GP Health of The Nation
As Australia’s largest professional general practice organisation, the RACGP represents more than 43,000 members, including more than 24,000 Fellows who have completed specialist training (or its equivalent). These are the frontline GPs who treat almost 22 million patients across the country every year.
Each year the runs a survey across Australian Doctors. This year’s report reflects the experience of more than 1300 RACGP Fellows from across Australia. Despite this and other achievements, the share of total government healthcare spend for primary care is in decline.
-
Warning signs of substance abuse and addiction
Tara Hurster, is the CEO of The TARA Clinic and a psychologist who started working within the area of addiction in 2010. The TARA clinic, short for Therapeutic Addiction Recovery Assistance, recently started offering online programs to overcome and recover from addiction.
Tara spoke with Australian Health Journal about the early warning signs of anxiety and stress in health staff and executives, including irritability, changes in sleep patterns and diet leading to more serious mental health decline. These behaviours and symptoms increase the risk of substance abuse that could take the form of excessive smoking, drinking alcohol and drug use, porn, sex and gambling.